Christopher Doyle, Ph.D.

Chris currently serves as an Institutional Biosafety Committee (IBC) Chair and Director of IBC Services at WCG, working with research sites, sponsors, and CROs to ensure human gene transfer clinical trials are conducted safely. Prior to joining WCG in early 2018, Chris was a research fellow at the Albert Einstein College of Medicine (Bronx, NY), where he explored mechanisms of antibody activity against Streptococcus pneumoniae.

Chris received his BA in Biology from Assumption College (Worcester, MA) in 2008 and his PhD in Molecular Genetics and Microbiology from Stony Brook University (Stony Brook, NY) in 2014, where he studied the pathogenesis of Francisella tularensis in a high containment Biosafety Level 3 laboratory. Chris has authored several peer-reviewed publications describing his past research, has served as an ad-hoc reviewer for Infection and Immunity, and is a member of the American Society for Microbiology (ASM) and the American Biological Safety Association (ABSA).